Altimmune Inc (ALT)
7.20
+0.12
(+1.69%)
USD |
NASDAQ |
Apr 25, 16:00
7.16
-0.04
(-0.56%)
After-Hours: 20:00
Altimmune Price: 7.20 for April 25, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 25, 2024 | 6.88 | 7.25 | 6.78 | 7.20 | 2.308M |
| Apr 24, 2024 | 7.55 | 7.75 | 6.98 | 7.08 | 2.205M |
| Apr 23, 2024 | 7.47 | 8.23 | 7.47 | 7.57 | 3.132M |
| Apr 22, 2024 | 7.03 | 7.55 | 6.85 | 7.47 | 2.370M |
| Apr 19, 2024 | 6.85 | 7.01 | 6.64 | 6.91 | 3.591M |
| Apr 18, 2024 | 6.97 | 7.26 | 6.85 | 6.89 | 3.216M |
| Apr 17, 2024 | 7.65 | 7.65 | 7.01 | 7.04 | 3.641M |
| Apr 16, 2024 | 7.42 | 7.65 | 7.23 | 7.52 | 2.724M |
| Apr 15, 2024 | 7.95 | 7.98 | 7.32 | 7.55 | 3.527M |
| Apr 12, 2024 | 8.33 | 8.33 | 7.75 | 7.99 | 3.046M |
| Apr 11, 2024 | 8.07 | 8.54 | 7.958 | 8.40 | 2.832M |
| Apr 10, 2024 | 8.05 | 8.35 | 7.96 | 8.01 | 2.894M |
| Apr 09, 2024 | 8.60 | 8.71 | 8.11 | 8.40 | 2.882M |
| Apr 08, 2024 | 9.09 | 9.15 | 8.55 | 8.61 | 2.340M |
| Apr 05, 2024 | 8.83 | 9.17 | 8.63 | 9.09 | 2.938M |
| Apr 04, 2024 | 9.35 | 9.52 | 8.86 | 8.90 | 3.050M |
| Apr 03, 2024 | 9.32 | 9.51 | 8.835 | 9.29 | 2.849M |
| Apr 02, 2024 | 9.90 | 9.90 | 9.20 | 9.355 | 3.636M |
| Apr 01, 2024 | 10.25 | 11.01 | 9.89 | 10.23 | 5.083M |
| Mar 28, 2024 | 9.06 | 10.50 | 8.84 | 10.18 | 8.496M |
| Mar 27, 2024 | 9.32 | 9.68 | 7.92 | 8.89 | 11.14M |
| Mar 26, 2024 | 8.82 | 9.10 | 8.61 | 8.65 | 2.959M |
| Mar 25, 2024 | 9.12 | 9.28 | 8.51 | 8.53 | 2.276M |
| Mar 22, 2024 | 8.97 | 9.33 | 8.895 | 9.08 | 1.709M |
| Mar 21, 2024 | 9.40 | 9.68 | 9.03 | 9.11 | 2.747M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.53
Minimum
Nov 19 2019
33.26
Maximum
Jul 20 2020
8.679
Average
8.87
Median
Jul 06 2021
Price Benchmarks
| Eli Lilly and Co | 724.87 |
| Amgen Inc | 269.38 |
| Viking Therapeutics Inc | 68.86 |
| Precision BioSciences Inc | 9.72 |
| Terns Pharmaceuticals Inc | 4.64 |
Price Related Metrics
| PS Ratio | 899.79 |
| Price to Book Value | 2.630 |
| Earnings Yield | -23.19% |
| Market Cap | 510.45M |